Neonatal NEC Risk Prediction via GI Microbiota Profiling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods lack a reliable approach to identify neonates at risk for necrotizing enterocolitis (NEC) before onset, as the role of microorganisms in NEC is controversial and diagnostic techniques based on microbiota analysis have not been considered viable.

Innovation Solution

A method involving profiling the gastrointestinal (GI) microbiota of neonates shortly after birth, correlating the profiles with standard samples from neonates who developed or did not develop NEC, to predict the risk of NEC by identifying significant correlations.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Loss of time

If microbiota analysis is performed to predict NEC risk, then early prediction capability is improved, but reliability is worsened due to controversial role of microorganisms in NEC

Engineering Contradiction:
Improveprediction timeVSAvoidprediction reliability
Core Design Contradiction:
Loss of timeVSReliability

Solution Approach 1:

The microbiota community is segmented into specific operational taxonomic units (OTUs) at different taxonomic levels (phylum, class, order, family, genus, species). This segmentation allows identification of specific bacterial groups associated with NEC risk, transforming the controversial general microbiota analysis into targeted detection of prognostic bacterial signatures, thereby improving reliability while maintaining early prediction capability

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention changes the parameter of analysis from general microbiota presence to specific quantitative profiles of bacterial OTUs. By measuring the abundance and composition of specific bacterial groups (such as Bifidobacterium, Lactobacillus, Clostridium clusters) and comparing them against established thresholds, the method transforms subjective controversial observations into objective quantifiable parameters, resolving the reliability issue

Inventive Principle:
Principle #35Parameter changes

2Loss of time

If GI microbiota profiling is performed soon after birth, then early prediction is enabled, but measurement precision is worsened due to difficulty in detecting microorganisms in neonatal GI tract

Engineering Contradiction:
Improvedetection timeVSAvoidmicrobiota detection precision
Core Design Contradiction:
Loss of timeVSMeasurement precision

Solution Approach 1:

The method performs preliminary action by collecting GI tract samples (meconium or early stool) immediately after birth or within the first few days of life, before NEC symptoms develop. This preliminary sampling captures the initial microbiota colonization pattern that predicts future NEC risk, enabling early prediction without waiting for disease manifestation or significant microbial growth that would compromise precision

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The invention replaces traditional culture-based mechanical detection methods with molecular techniques such as 16S rRNA gene sequencing or quantitative PCR. This substitution overcomes the limitations of culturing fastidious neonatal gut bacteria, enabling precise detection and identification of microbiota composition from minimal early samples, thereby maintaining measurement precision while achieving early detection

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Data Source

PatentUS9376724B2Method for identifying neonates at risk for necrotizing enterocolitis
Publication Date: 2016.06.28 GENETIC ANALYSIS
  • US9376724B2 patent drawing
  • US9376724B2 patent drawing

AI summary

The invention provides a method for identifying a neonatal subject at risk for NEC, said method comprising (a) profiling the microbiota in a sample from the GI tract of said subject prior to a conclusive diagnosis of NEC and/or prior to full onset of NEC, (b1) comparing said profile to a standard microbiota profile obtained from corresponding samples from neonatal subjects with NEC or subjects which later developed NEC and determining the degree of correlation between said profile and the standard profile(s), and/or (b2) comparing said profile to a standard microbiota profile obtained from corresponding samples from neonatal subjects which did not develop NEC and determining the degree of correlation between said profile and the standard profile, and (c) identifying the subject as being at risk of NEC if significant correlation is observed in (b1) and/or significant correlation is not seen in (b2). An oligonucleotide probe set for use in the method of the invention, and kits containing the same, are also provided.